Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies. | Biomark Res | 2025 | 40361241 | PubTator, text mining | PubMed |
| InDeepNet: a web platform for predicting functional binding sites in proteins using InDeep. | Nucleic Acids Res | 2025 | 40337922 | PubTator, text mining | PubMed |
| Cellular parameters shaping pathways of targeted protein degradation. | Commun Biol | 2025 | 40316744 | PubTator, text mining | PubMed |
| Crystal structures of Kif2A complexed with WDR5 reveal the structural plasticity of WIN-S7 sites. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40302551 | PubTator, text mining | PubMed |
| Biomolecules Interacting with Long Noncoding RNAs. | Biology (Basel) | 2025 | 40282307 | PubTator, text mining | PubMed |
| Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma. | Sci Adv | 2025 | 40267190 | PubTator, text mining | PubMed |
| The m6A hypermethylation-induced PIR overexpression regulates H3K4me3 and promotes tumorigenesis of uveal melanoma. | Cancer Lett | 2025 | 40252822 | PubTator, text mining | PubMed |
| Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease. | JTO Clin Res Rep | 2025 | 40236262 | PubTator, text mining | PubMed |
| HBx/WDR5 enhances IGF-1 transcription in hepatocellular carcinoma cells and promotes recruitment, infiltration, and activity of Treg cells. | Immunol Res | 2025 | 40199768 | PubTator, text mining | PubMed |
| Two is better than one: dual targeting of WDR5 in T-ALL. | Blood | 2025 | 40146156 | PubTator, text mining | PubMed |
| Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation. | Cancer Innov | 2025 | 40094073 | PubTator, text mining | PubMed |
| Cyclic mechanical stress promotes osteogenic differentiation of periodontal ligament stem cells via KAT2A-mediated succinylation of WDR5. | Tissue Cell | 2025 | 40073466 | PubTator, text mining | PubMed |
| Inhibition of the MLL1-WDR5 interaction modulates epithelial to mesenchymal transition and metabolic pathways in triple-negative breast cancer cells. | Biochem Biophys Res Commun | 2025 | 40043619 | PubTator, text mining | PubMed |
| Understanding lncRNAs: key regulators of myogenesis and lipogenesis in farm animals. | Front Vet Sci | 2025 | 40027357 | PubTator, text mining | PubMed |
| Comprehensive analysis of RNA-chromatin, RNA-, and DNA-protein interactions. | NAR Genom Bioinform | 2025 | 40007725 | PubTator, text mining | PubMed |
| Applying an updated brain injury guideline classification to interhospital transfer of patients with traumatic brain injury: Who benefits most? | Clin Neurol Neurosurg | 2025 | 39994934 | PubTator, text mining | PubMed |
| Correction: Macrocyclic peptides as inhibitors of WDR5-lncRNA interactions. | Chem Commun (Camb) | 2025 | 39957546 | PubTator, text mining | PubMed |
| pyBinder: Quantitation to Advance Affinity Selection-Mass Spectrometry. | Anal Chem | 2025 | 39949296 | PubTator, text mining | PubMed |
| Evaluating the brain injury guidelines (BIG) in an Australian trauma centre: A retrospective cohort analysis. | J Clin Neurosci | 2025 | 39889522 | PubTator, text mining | PubMed |
| Catalytic-independent functions of the Integrator-PP2A complex (INTAC) confer sensitivity to BET inhibition. | Nat Chem Biol | 2025 | 39809894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=6